Dry eye cases rise with heavy screen use and younger patients; learn modern workups spotlighting MGD, etiology-driven treatments, and collaborative care reshaping outcomes.
|Videos|May 1, 2021
Comparison of clinical outcomes of Schirmer's test with dry eye
Author(s)OT Staff Reports, Sheryl Stevenson
Jeffrey Gemi, MD, Ora Inc., speaks on the highlights from his presentation comparing Schirmer's test with other clinical outcomes in dry eye.
Advertisement
Jeffrey Gemi, MD, director of Special Projects, Anterior Segments, Ora Inc., speaks on the highlights from a presentation on comparing Schirmer's test with other clinical outcomes in dry eye during the virtual ARVO 2021 meeting.
Advertisement
Related to this article
Optometrist–ophthalmologist co-management targets dry eye early, improves cataract and refractive surgery satisfaction, and uses advanced diagnostics and treatments for healthier ocular surfaces.
Their conversation covers a holistic, cross-specialty approach to ocular surface disease and the unmet need driving a new model of dry eye care in Ireland.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Comments from the FDA Advisory Committee meeting on SYD-101
2
Q&A: Phentolamine for presbyopia: a non-miotic route to near vision
3
Retinal imaging as a window into atrial fibrillation
4
Stool biomarker uncovers silent bowel disease in uveitis patients
5